Literature DB >> 16788784

[B-cell lymphoma of the testes].

V Zugor1, M Frank, F S Krause, G E Schott, T Aigner, D G Engehausen.   

Abstract

The occurrence of primary non-Hodgkin's lymphomas of the testes is described in just a few studies in the urological literature. The clinical symptomatology and especially the treatment concept for this relatively rare tumor entity are hardly discussed. Imaging diagnostics, e.g., with CT or MRI, play a decisive role in determining the diagnosis and whether a primary testicular disease is involved or a generalized systemic disease. In cases of primary B-cell lymphomas of the testes, a high inguinal orchiectomy should be performed for diagnostic and therapeutic purposes. The standard chemotherapy for aggressive non-Hodgkin's lymphomas is the CHOP regimen consisting of cyclophosphamide, doxorubicin, vincristine, and prednisone. This article presents two adults aged 67 and 75 years with histologically proven B-cell lymphoma of the testes and discusses the characteristics of this relatively rare clinical picture as well as treatment and prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16788784     DOI: 10.1007/s00120-006-1081-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  5 in total

Review 1.  Testicular lymphoma.

Authors:  N Shahab; D C Doll
Journal:  Semin Oncol       Date:  1999-06       Impact factor: 4.929

2.  Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO.

Authors:  M B Møller; F d'Amore; B E Christensen
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

3.  Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study.

Authors:  Sverker Hasselblom; Börje Ridell; Hans Wedel; Klas Norrby; Monica Sender Baum; Tor Ekman
Journal:  Acta Oncol       Date:  2004       Impact factor: 4.089

4.  Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?

Authors:  C Visco; L J Medeiros; O M Mesina; M A Rodriguez; F B Hagemeister; P McLaughlin; J E Romaguera; F Cabanillas; A H Sarris
Journal:  Clin Lymphoma       Date:  2001-06

5.  Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.

Authors:  E Zucca; A Conconi; T I Mughal; A H Sarris; J F Seymour; U Vitolo; R Klasa; M Ozsahin; G M Mead; M A Gianni; S Cortelazzo; A J M Ferreri; A Ambrosetti; M Martelli; C Thiéblemont; H Gomez Moreno; G Pinotti; G Martinelli; R Mozzana; S Grisanti; M Provencio; M Balzarotti; F Laveder; G Oltean; V Callea; P Roy; F Cavalli; M K Gospodarowicz
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.